Cross-talk between non-ionizing electromagnetic fields and metastasis; EMT and hybrid E/M may explain the anticancer...

Area of Science:

• Biophysics
• Oncology
• Cell Biology

Background:

• Non-ionizing electromagnetic fields (NIEMFs) exhibit potential anti-cancer properties against various cancer cells.
• Metastasis, the spread of cancer, is a primary cause of cancer-related mortality and involves complex cellular processes.
• Epithelial-mesenchymal transition (EMT) is a key biological process implicated in cancer metastasis, embryogenesis, and tissue regeneration.

Purpose of the Study:

• To elucidate the precise mechanisms by which NIEMFs exert anti-cancer effects.
• To investigate the potential impact of NIEMFs on critical epithelial-mesenchymal transition (EMT) molecules and pathways involved in cancer metastasis.

Main Methods:

• Literature review and critical analysis of existing studies on NIEMFs and cancer.
• Discussion of key EMT-related molecules and pathways potentially modulated by NIEMFs, including VEGFR, ROS, P53, PI3K/AKT, MAPK, Cyclin B1, and NF-κB.

Main Results:

• Evidence suggests that NIEMFs may influence EMT-related pathways, offering a potential mechanism for their anti-cancer effects.
• Specific molecular targets like VEGFR, ROS, P53, PI3K/AKT, MAPK, Cyclin B1, and NF-κB are identified as potentially affected by NIEMFs.

Conclusions:

• Understanding the interaction between NIEMFs and EMT pathways is crucial for developing novel anti-cancer therapies.
• NIEMFs represent a promising area of research for targeting cancer metastasis through modulation of key cellular signaling pathways.